Hennion & Walsh Asset Management, Inc. Eli Lilly & CO Transaction History
Hennion & Walsh Asset Management, Inc.
- $2.15 Billion
- Q1 2025
A detailed history of Hennion & Walsh Asset Management, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Hennion & Walsh Asset Management, Inc. holds 14,083 shares of LLY stock, worth $10.5 Million. This represents 0.54% of its overall portfolio holdings.
Number of Shares
14,083
Previous 14,918
5.6%
Holding current value
$10.5 Million
Previous $11.5 Million
1.0%
% of portfolio
0.54%
Previous 0.55%
Shares
17 transactions
Others Institutions Holding LLY
# of Institutions
4,404Shares Held
807MCall Options Held
9.91MPut Options Held
10.9M-
Pnc Financial Services Group, Inc. Pittsburgh, PA101MShares$75.6 Billion44.13% of portfolio
-
Lilly Endowment Inc Indianapolis, IN96MShares$71.7 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA79.2MShares$59.1 Billion1.22% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$49.2 Billion1.37% of portfolio
-
State Street Corp Boston, MA34.4MShares$25.7 Billion1.2% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $709B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...